These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1362592)

  • 1. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    Horiguchi J; Nishimatsu O
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of clonazepam and placebo in the treatment of neuroleptic-induced akathisia.
    Pujalte D; Bottaï T; Huë B; Alric R; Pouget R; Blayac JP; Petit P
    Clin Neuropharmacol; 1994 Jun; 17(3):236-42. PubMed ID: 9316669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study.
    Kutcher S; Williamson P; MacKenzie S; Marton P; Ehrlich M
    J Clin Psychopharmacol; 1989 Dec; 9(6):403-6. PubMed ID: 2574191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with clonazepam for neuroleptic-induced akathisia.
    Horiguchi J; Nishimatsu O; Inami Y
    Acta Psychiatr Scand; 1989 Jul; 80(1):106-7. PubMed ID: 2569804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo response in refractory tardive akathisia.
    Remington G; Fornazzari L; Sethna R
    Can J Psychiatry; 1993 May; 38(4):248-50. PubMed ID: 8100184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Handedness as a risk factor for neuroleptic-induced movement disorders.
    Brown KW; White T; Anderson F; McGilp R
    Biol Psychiatry; 1992 Apr; 31(7):746-8. PubMed ID: 1350923
    [No Abstract]   [Full Text] [Related]  

  • 8. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
    Manos N; Gkiouzepas J; Logothetis J
    Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics.
    Manos N; Lavrentiadis G; Gkiouzepas J
    J Clin Psychiatry; 1986 Mar; 47(3):114-6. PubMed ID: 2869027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of antiparkinson drug withdrawal.
    Jellinek T; Gardos G; Cole JO
    Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.
    Hansen L; Jones RM; Kingdon D
    J Psychopharmacol; 2004 Sep; 18(3):384-7. PubMed ID: 15358982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of drug-induced akathisia: Part I. Acute akathisia.
    Sachdev P
    Schizophr Bull; 1995; 21(3):431-49. PubMed ID: 7481574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of neuroleptic-induced akathisia to drug-induced parkinsonism.
    Sandyk R; Kay SR
    Ital J Neurol Sci; 1990 Oct; 11(5):439-42. PubMed ID: 1980270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
    Tugg LA; Desai D; Prendergast P; Remington G; Reed K; Zipursky RB
    Schizophr Res; 1997 May; 25(1):71-8. PubMed ID: 9176929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of tardive dystonia with clozapine and clonazepam.
    Shapleske J; Mickay AP; Mckenna PJ
    Br J Psychiatry; 1996 Apr; 168(4):516-8. PubMed ID: 8730951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysphagia: a rare form of dyskinesia?
    Nieves JE; Stack KM; Harrison ME; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):199-201. PubMed ID: 17522565
    [No Abstract]   [Full Text] [Related]  

  • 19. Periodic limb movement disorder in neuroleptic-induced akathisia.
    Nishimatsu O; Horiguchi J; Inami Y; Sukegawa T; Sasaki A
    Kobe J Med Sci; 1997 Oct; 43(5):169-77. PubMed ID: 9642972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.